Add BrightSurf on Google Email

Bacterial genomes hold clues for creating personalized probiotics

Researchers created an 'encyclopedia of sugar utilization pathways' in 263 Bifidobacterium genomes. This resource helps predict which strains thrive in different conditions, enabling personalized probiotics to match children's lifestyles and dietary needs. The study suggests a potential solution to improving outcomes for preterm infants.

SourceSanford Burnham Prebys·JournalNature Microbiology·TypeExperimental study·DateJul 16, 2025

Nighttime pistachio snacking may reshape gut microbiome in prediabetic adults

A new study found that consuming pistachios every night for 12 weeks altered bacteria in the gut of adults with prediabetes, increasing beneficial short-chain fatty acids like butyrate. The changes may offer long-term health benefits, potentially slowing Type 2 diabetes development or reducing inflammation.

SourcePenn State·JournalCurrent Developments in Nutrition·TypeRandomized controlled/clinical trial·DateJul 14, 2025

Gut morphology, not just diet or phylogeny, shapes mammalian gut microbiomes

Researchers analyzed over 1,400 gut microbiome samples from 292 mammalian species to find distinct gut microbiomes corresponding to different gut morphology types. These microbiomes were grouped into three enterotypes: Fusobacterium in simple-gut species, UCG-005 in foregut fermenters, and Prevotella in hindgut fermenters.

SourceScience China Press·JournalScience China Life Sciences·TypeMeta-analysis·DateJul 10, 2025

The gut microbiota in elderly patients with acute hepatitis E infection

The study found that elderly patients with acute hepatitis E infection have distinct gut microbiota compositions compared to healthy controls. The relative abundance of Bacteroides fragilis was significantly associated with disease outcomes, including self-healing and non-self-healing cases. This suggests a potential role for Bacteroid...

SourceXia & He Publishing Inc.·JournalJournal of Clinical and Translational Hepatology·DateJul 8, 2025

Multiple sclerosis: Triggers in the gut flora

A study of twins reveals that certain bacteria in the small intestine may trigger MS. Researchers identified two specific bacteria, Lachnoclostridium sp and Eisenbergiella tayi, which are associated with the disease. The findings suggest a new potential therapeutic target for MS treatment.

SourceMax-Planck-Gesellschaft·JournalProceedings of the National Academy of Sciences·DateJun 5, 2025

Gut bacteria and acetate, a great combination for weight loss

A study published in Cell Metabolism finds that a combination of gut bacteria and acetate reduces obesity in mice. The researchers discovered that the specific combination of Bacteroides species and acetate leads to increased fat burning and reduced sugar storage, resulting in weight loss.

SourceRIKEN·JournalCell Metabolism·DateMay 19, 2025

Invasive rats and rainforest mammals are sharing gut microbes as urban areas grow

A study by Swansea University reveals that native and invasive small mammals are sharing their gut microbes as habitats change, highlighting the importance of microbiome similarity in adaptation to new environments. This finding has implications for understanding the impact of urbanization on wildlife health and disease spread.

SourceSwansea University·JournalMolecular Ecology·TypeExperimental study·DateMay 1, 2025

Marshall researchers explore gut microbiota’s role in sleep apnea in new review published in Sleep Medicine

A new review from Marshall University researchers highlights emerging connections between gut health and sleep apnea, pointing to potential new therapeutic approaches for managing this common disorder. Alterations in gut microbiota composition have been consistently observed in individuals with sleep apnea, inducing systemic inflammati...

SourceMarshall University Joan C. Edwards School of Medicine·JournalSleep Medicine·TypeLiterature review·DateApr 14, 2025

HKU cross-disciplinary research reveals oral microbiota as promising screening tool for young children with autism spectrum disorder (ASD)

A cross-disciplinary research team from HKU has found a connection between oral microbiota and ASD, identifying 11 bacterial species as potential biomarkers. The study developed a prediction model with an 81% accuracy rate for early detection, paving the way for non-invasive screening tools during dental check-ups.

SourceThe University of Hong Kong·JournalJournal of Dentistry·TypeExperimental study·DateApr 8, 2025

New Cedars-Sinai study shows how specialized diet can improve gut disorders

A new study from Cedars-Sinai examined the effectiveness of a specialized diet in improving symptoms of gastrointestinal disorders linked to an imbalance in gut microbiota. The research found that most participants reported tolerating the diet well and experienced significant relief from common symptoms like bloating and discomfort.

SourceCedars-Sinai Medical Center·JournalClinical Gastroenterology and Hepatology·TypeRandomized controlled/clinical trial·DateApr 1, 2025

Correcting imbalance with the gut microbiota after stroke could reduce brain inflammation, open pathway to potential therapies

Researchers found that changes in gut bacteria after a stroke lead to an increase in harmful substances and a decrease in beneficial ones, potentially causing inflammation. Restoring these beneficial substances from gut bacteria could help reduce inflammation after a stroke.

SourceUniversity of Texas Health Science Center at Houston·JournalNature Communications·TypeExperimental study·DateMar 24, 2025

The emerging role of flavonoids in the treatment of type 2 diabetes mellitus: regulating the enteroendocrine system

Research suggests flavonoids improve insulin sensitivity, enhance β-cell function, modulate the gut microbiota, inhibit gluconeogenesis, and regulate enteroendocrine hormones in type 2 diabetes management. Flavonoid-specific effects on GLP-1, GIP, PYY, and CCK secretion contribute to improved glycemic control.

SourceXia & He Publishing Inc.·JournalExploratory Research and Hypothesis in Medicine·DateMar 20, 2025

Effects of electroacupuncture combined with Chinese herbal medicine on gut microbiota and metabolomics in amyotrophic lateral sclerosis

Researchers investigated the effects of electroacupuncture on gut microbiota and metabolomics in ALS patients, finding a reduction in Eisenbergiella abundance and improvements in Lachnospiraceae levels. The study suggests that this treatment may be beneficial for patients with ALS.

SourceXia & He Publishing Inc.·JournalFuture Integrative Medicine·DateMar 7, 2025

Synthetic microbiome therapy suppresses bacterial infection without antibiotics

Researchers developed a synthetic microbiome therapy using limited strains of gut bacteria to effectively protect against C. difficile infections in mice. The treatment was as effective as traditional fecal transplants and had fewer safety concerns, offering a new alternative for treating this notoriously difficult-to-treat infection.

SourcePenn State·JournalCell Host & Microbe·TypeObservational study·DateMar 3, 2025

Unexpected discoveries in study of giraffe gut flora

Researchers have discovered that giraffes maintain species-specific gut flora, even when eating different sets of plants. This finding has significant implications for the conservation of endangered giraffe species, highlighting the importance of understanding their diets and habitats to ensure their survival.

SourceUppsala University·JournalGlobal Ecology and Conservation·TypeObservational study·DateFeb 24, 2025

Stalled microbiomes: Dartmouth-led study reveals that cystic fibrosis disrupts early gut development in infants

A Dartmouth-led study reveals that cystic fibrosis disrupts the maturation of the gut microbiome in infants, leading to a depletion of health-associated bacteria and potentially poor health outcomes. The study found that the microbiomes of infants with CF remained stunted or delayed in their development compared to healthy infants.

Microbiome as a potential key to better treatment: Clinical study on new therapy for Crohn's disease

Researchers at TUM have developed a new therapeutic approach combining dietary therapy with fecal microbiome transfer to sustain inflammation-free states in Crohn's disease patients. The study found that the gut microbiome changes as a result of dietary therapy contribute to treatment success.

SourceTechnical University of Munich (TUM)·JournalCell Host & Microbe·TypeRandomized controlled/clinical trial·DateFeb 11, 2025